164 related articles for article (PubMed ID: 12835699)
1. CpG motifs: the active ingredient in bacterial extracts?
Krieg AM
Nat Med; 2003 Jul; 9(7):831-5. PubMed ID: 12835699
[TBL] [Abstract][Full Text] [Related]
2. Bacterial DNA activates human neutrophils by a CpG-independent pathway.
Trevani AS; Chorny A; Salamone G; Vermeulen M; Gamberale R; Schettini J; Raiden S; Geffner J
Eur J Immunol; 2003 Nov; 33(11):3164-74. PubMed ID: 14579285
[TBL] [Abstract][Full Text] [Related]
3. [Cancer immunotherapy with CpG-ODN].
Carpentier AF
Med Sci (Paris); 2005 Jan; 21(1):73-7. PubMed ID: 15639024
[TBL] [Abstract][Full Text] [Related]
4. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
5. TLR9 signals after translocating from the ER to CpG DNA in the lysosome.
Latz E; Schoenemeyer A; Visintin A; Fitzgerald KA; Monks BG; Knetter CF; Lien E; Nilsen NJ; Espevik T; Golenbock DT
Nat Immunol; 2004 Feb; 5(2):190-8. PubMed ID: 14716310
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors involved in the response to microbial pathogens: development of agonists for toll-like receptor 9.
Schetter C; Vollmer J
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):204-10. PubMed ID: 15603254
[TBL] [Abstract][Full Text] [Related]
7. Signaling in B cells via Toll-like receptors.
Peng SL
Curr Opin Immunol; 2005 Jun; 17(3):230-6. PubMed ID: 15886111
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of TLR9 activation.
Latz E; Visintin A; Espevik T; Golenbock DT
J Endotoxin Res; 2004; 10(6):406-12. PubMed ID: 15588423
[TBL] [Abstract][Full Text] [Related]
9. CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infections.
Harandi AM; Holmgren J
Curr Opin Investig Drugs; 2004 Feb; 5(2):141-5. PubMed ID: 15043387
[TBL] [Abstract][Full Text] [Related]
10. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.
Wilson HL; Dar A; Napper SK; Marianela Lopez A; Babiuk LA; Mutwiri GK
Int Rev Immunol; 2006; 25(3-4):183-213. PubMed ID: 16818371
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.
Rutz M; Metzger J; Gellert T; Luppa P; Lipford GB; Wagner H; Bauer S
Eur J Immunol; 2004 Sep; 34(9):2541-50. PubMed ID: 15307186
[TBL] [Abstract][Full Text] [Related]
12. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
[TBL] [Abstract][Full Text] [Related]
13. Cultured astrocytes express toll-like receptors for bacterial products.
Bowman CC; Rasley A; Tranguch SL; Marriott I
Glia; 2003 Sep; 43(3):281-91. PubMed ID: 12898707
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
[TBL] [Abstract][Full Text] [Related]
15. Immunology: DNA drives autoimmunity.
Vinuesa CG; Goodnow CC
Nature; 2002 Apr; 416(6881):595-8. PubMed ID: 11948338
[No Abstract] [Full Text] [Related]
16. The immunobiology of the TLR9 subfamily.
Wagner H
Trends Immunol; 2004 Jul; 25(7):381-6. PubMed ID: 15207506
[No Abstract] [Full Text] [Related]
17. CpG DNA: security code for host defense.
Medzhitov R
Nat Immunol; 2001 Jan; 2(1):15-6. PubMed ID: 11135571
[No Abstract] [Full Text] [Related]
18. [Immunology--risk management in the body].
Kabelitz D
Dtsch Med Wochenschr; 2005 Jun; 130(25-26):1563-5. PubMed ID: 15965863
[No Abstract] [Full Text] [Related]
19. Heat-shock proteins and the host-pathogen interaction during bacterial infection.
Stewart GR; Young DB
Curr Opin Immunol; 2004 Aug; 16(4):506-10. PubMed ID: 15245747
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide-binding-oligomerization domain proteins and toll-like receptors: sensors of the inflammatory bowel diseases' microbial environment.
Mueller T; Podolsky DK
Curr Opin Gastroenterol; 2005 Jul; 21(4):419-25. PubMed ID: 15930981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
